Security Check
Dr. Wen-Zhao Zhong

Dr. Wen-Zhao Zhong, MD, Ph.D.

Senior Consultant
Code: 110440000001970
Surgery-Led MDT VATS Radical Resection Stage IIIA-N2 Management SPN/GGO Triage Minimally Invasive Surgery Perioperative Precision Therapy
Experience20+ years
LanguagesEnglish | 中文
Typical turnaround3–5 business days
Second-opinion formatWritten review

Overview

Professor Wen-Zhao Zhong, MD, PhD, is a Chief Physician, Doctoral Supervisor, and the Director of the Department of Thoracic Surgery at Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences). He is a leading figure among young and middle-aged thoracic surgery experts in China, with significant international influence in minimally invasive surgery for early-stage lung cancer and perioperative targeted/immunotherapy.

Board Certification
Pulmonary Surgery
Clinical Focus
Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | Small Cell Lung Cancer (SCLC)
Approach
Guideline-driven + personalized
Best for
New diagnosis · Recurrence · Complex decisions
Clinical focus & conditions

Lung Cancer (NSCLC, SCLC)
Lung Adenocarcinoma
Pulmonary Ground-Glass Opacity (GGO)
Solitary Pulmonary Nodule
Multidisciplinary Treatment of Stage III N2 Lung Cancer
Lung Cancer Brain / Skin / Liver Metastasis
Perioperative targeted therapy resistance in lung cancer
High-grade Neuroendocrine Tumors

Education & training

MD,Ph.D. — Sun Yat-sen University School of Medicine
Advanced clinical training at GLCI; international cancer center exchange scholar.

Hospital affiliations

Guangdong Provincial People's Hospital

Honors & Research

Board Member, International Association for the Study of Lung Cancer (IASLC).
Associate Editor, Journal of Thoracic Oncology (JTO, IF 20.1), Official Journal of IASLC.
Reviewer, National Natural Science Foundation of China (NSFC).
Council Member, CSCO; Deputy Chairman, Youth Committee; Head of Lung Cancer Specialty Group, Chinese Society of Clinical Oncology (CSCO).
National S&T Progress Award (2nd Class)
Guangdong "Special Support Plan" Leading Talent
Pearl River Scholar
Pivotal Trial Lead (CTONG1104): Redefined global lung cancer guidelines.
Prolific Author: 100+ SCI publications in JCO, Lancet Oncology, etc.
Principal Investigator (PI): Multiple NSFC (National Natural Science Foundation) grants.

Is my case a fit for a second opinion?

A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results  progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.

Important note

This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.